Unravel Biosciences, Inc.

New Filing
CIK: 0001876967·Biotechnology·DELAWARE·Filed: Aug 24, 2026
Total Offering

$4,500,000

Amount Sold

$4,100,000

Investors

2

First Sale

Aug 7, 2026

Offering Details

Type
Debt, Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Richard Novak
Frederic Vigneault
Donald Ingber

Company

Unravel Biosciences, Inc.

196 BOSTON AVE., SUITE 1000

MEDFORD, MA, 02155

510-984-2317

SEC Filing

0001876967-26-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Unravel Biosciences, Inc. Form D Filing — $4,500,000 | FilingFlow